drugset / Trial / NCT01034683

Study of Lobaplatin,5-Fluorouracil and Leucovorin for the Treatment of Esophageal Carcinoma

NCT01034683

Phase 3 Unknown 120 enrolled Taian Cancer Hospital
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy and the toxicity of lobaplatin, 5-fluorouracil (5-FU) and leucovorin in patients with esophageal carcinoma.

Timeline

Start
2009-12
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Leucovorin Small molecule 200 mg/m2
Subject Lobaplatin Small molecule 30 mg/m2
Subject fluorouracil Small molecule 650 mg/m2